Psychedelic Revolution: This Biotech Company Wins Two Major Patents

Cybin Inc. Advances Psychedelic Research with Two New Patents for Deuterated DMT Program.

Cybin Inc., a leading biotechnology company focused on progressing psychedelic therapeutics, announced the grant of two new United States patents related to its Deuterated N, N-Dimethyltryptamine (DMT) program. This breakthrough has the potential to revolutionize the mental health sector and it could have significant implications for millions of people …